Single Ascending Dose Study of PRX003 in Healthy Subjects
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
This single ascending dose study is to determine safety, tolerability, pharmacokinetics and
immunogenicity of PRX003 in approximately 40 healthy subjects.